Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
63.84
-0.64 (-0.99%)
At close: Mar 28, 2025, 4:00 PM
63.00
-0.84 (-1.32%)
After-hours: Mar 28, 2025, 6:54 PM EDT

Halozyme Therapeutics Revenue

In the year 2024, Halozyme Therapeutics had annual revenue of $1.02B with 22.44% growth. Halozyme Therapeutics had revenue of $298.01M in the quarter ending December 31, 2024, with 29.55% growth.

Revenue (ttm)
$1.02B
Revenue Growth
+22.44%
P/S Ratio
7.97
Revenue / Employee
$2,900,926
Employees
350
Market Cap
7.86B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.02B186.07M22.44%
Dec 31, 2023829.25M169.14M25.62%
Dec 31, 2022660.12M216.81M48.91%
Dec 31, 2021443.31M175.72M65.67%
Dec 31, 2020267.59M71.60M36.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.